Robert O. Cotes, MD

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia

JCP
Clinical Follow-Up and Widening LAI Intervals
Commentary

May 31, 2023

Although the administration intervals of long-acting injectable antipsychotics are a starting point for scheduling follow-ups, frequency of prescriber contact should be based on individual risk factors and real-world constraints.
Samuel J. Dotson, Robert O. Cotes, Oliver Freudenreich
JCP
Protective Effect of Clozapine on Suicide
Original Research

March 15, 2023

Clozapine, which has shown promise in reducing suicidal behavior in schizophrenia, also appears to lower the odds of suicide death in the general population.
Brian J. Lee, Robert O. Cotes, Ramin Mojtabai, et al
PCC
Letter to the Editor

November 29, 2018

Is lithium needed long term after clozapine rechallenge? Do individuals develop neutropenia or agranulocytosis after lithium is discontinued? The authors of this report analyzed all of the available literature...
Mina Boazak, David R. Goldsmith, Robert O. Cotes
PCC
Letter to the Editor

August 3, 2017

Clinicians should be able to recognize and manage potential side effects of clozapine, including myocarditis. However, treatment guidelines do not currently recommend a monitoring protocol for clozapine-induced myocarditis. This...
David R. Goldsmith, Robert O. Cotes

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe